<DOC>
	<DOCNO>NCT02368210</DOCNO>
	<brief_summary>This Phase 3 study ( Study 306 ) design determine compare efficacy safety 122-0551 Foam Vehicle Foam apply twice daily two week subject plaque psoriasis .</brief_summary>
	<brief_title>A Comparison 122-0551 Foam Versus Vehicle Foam Subjects With Plaque Psoriasis ( Study 306 )</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Subject clinical diagnosis stable plaque psoriasis involve minimum 2 % 12 % affect body surface area . Subject Investigator 's Global Assessment ( IGA ) score least three ( moderate ) study start . If subject woman childbearing potential , must negative urine pregnancy test agree use effective form birth control duration study . Subject spontaneously improve rapidly deteriorate plaque psoriasis . Subject guttate , pustular , erythrodermic nonplaque form psoriasis . Subject physical condition , investigator 's opinion , might impair evaluation plaque psoriasis , expose subject unacceptable risk study participation . Subject use phototherapy ( include laser ) , photochemotherapy form photo base therapy treatment psoriasis within 30 day prior study start . Subject use systemic methotrexate , retinoids , systemic corticosteroid [ include intralesional , intraarticular , intramuscular corticosteroid ] , cyclosporine analogous product within 90 day prior study start . Subject use systemic biologic therapy ( i.e. , FDAapproved experimental therapy ) within five halflives biologic prior study start . Subject prolonged exposure natural artificial source ultraviolet radiation within 30 day prior study start intending exposure study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>